Recent advances in CFTR modulator therapy in the management of cystic fibrosis: Best practices for improved patient outcomes

Peter J. Mogayzel

Recent advances in CFTR modulator therapy in the management of cystic fibrosis: Best practices for improved patient outcomes

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Treatments targeting the underlying pathophysiology of cystic fibrosis are now available. These treatments are slowing declines in lung function from the disease. Survival is likely to continue to improve and a cure may even be possible.

Original language	English (US)
Pages (from-to)	52-56
Number of pages	5
Journal	Journal of Managed Care Medicine
Volume	22
Issue number	1
State	Published - 2019

ASJC Scopus subject areas

Health Policy

Cite this

@article{b6028e984e2e483c8107ec4b5abc2baf,

title = "Recent advances in CFTR modulator therapy in the management of cystic fibrosis: Best practices for improved patient outcomes",

abstract = "Treatments targeting the underlying pathophysiology of cystic fibrosis are now available. These treatments are slowing declines in lung function from the disease. Survival is likely to continue to improve and a cure may even be possible.",

author = "Mogayzel, {Peter J.}",

year = "2019",

language = "English (US)",

volume = "22",

pages = "52--56",

journal = "Journal of Managed Care Medicine",

issn = "1094-1525",

publisher = "National Association of Managed Care Physicians",

number = "1",

}

TY - JOUR

T1 - Recent advances in CFTR modulator therapy in the management of cystic fibrosis

T2 - Best practices for improved patient outcomes

AU - Mogayzel, Peter J.

PY - 2019

Y1 - 2019

N2 - Treatments targeting the underlying pathophysiology of cystic fibrosis are now available. These treatments are slowing declines in lung function from the disease. Survival is likely to continue to improve and a cure may even be possible.

AB - Treatments targeting the underlying pathophysiology of cystic fibrosis are now available. These treatments are slowing declines in lung function from the disease. Survival is likely to continue to improve and a cure may even be possible.

UR - http://www.scopus.com/inward/record.url?scp=85118925105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118925105&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85118925105

SN - 1094-1525

VL - 22

SP - 52

EP - 56

JO - Journal of Managed Care Medicine

JF - Journal of Managed Care Medicine

IS - 1

ER -

Recent advances in CFTR modulator therapy in the management of cystic fibrosis: Best practices for improved patient outcomes

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this